These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38361619)

  • 1. Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB.
    Scarcella M; Scerra G; Ciampa M; Caterino M; Costanzo M; Rinaldi L; Feliciello A; Anzilotti S; Fiorentino C; Renna M; Ruoppolo M; Pavone LM; D'Agostino M; De Pasquale V
    iScience; 2024 Mar; 27(3):108959. PubMed ID: 38361619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
    Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
    Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism.
    De Pasquale V; Caterino M; Costanzo M; Fedele R; Ruoppolo M; Pavone LM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses.
    Monaco A; Fraldi A
    Autophagy; 2021 Nov; 17(11):3875-3876. PubMed ID: 34407725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
    De Pasquale V; Sarogni P; Pistorio V; Cerulo G; Paladino S; Pavone LM
    Mol Ther Methods Clin Dev; 2018 Sep; 10():8-16. PubMed ID: 29942826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB.
    De Pasquale V; Pezone A; Sarogni P; Tramontano A; Schiattarella GG; Avvedimento VE; Paladino S; Pavone LM
    Cell Death Dis; 2018 Jan; 9(2):40. PubMed ID: 29348482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis III: Molecular basis and treatment.
    Spahiu L; Behluli E; Peterlin B; Nefic H; Hadziselimovic R; Liehr T; Temaj G
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):201-208. PubMed ID: 34743503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.
    Harm TA; Hostetter SJ; Nenninger AS; Valentine BN; Ellinwood NM; Smith JD
    Vet Pathol; 2021 Jan; 58(1):205-222. PubMed ID: 33205707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice.
    Malinowska M; Wilkinson FL; Bennett W; Langford-Smith KJ; O'Leary HA; Jakobkiewicz-Banecka J; Wynn R; Wraith JE; Wegrzyn G; Bigger BW
    Mol Genet Metab; 2009 Nov; 98(3):235-42. PubMed ID: 19632871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.
    Fu H; Meadows AS; Pineda RJ; Mohney RP; Stirdivant S; McCarty DM
    Metab Brain Dis; 2017 Oct; 32(5):1403-1415. PubMed ID: 28382573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
    Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
    Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine ameliorates mucopolysaccharidosis type IIIA.
    Capuozzo A; Montefusco S; Cacace V; Sofia M; Esposito A; Napolitano G; Nusco E; Polishchuk E; Pizzo MT; De Risi M; De Leonibus E; Sorrentino NC; Medina DL
    Mol Ther; 2022 Apr; 30(4):1432-1450. PubMed ID: 35121108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease.
    Monaco A; Maffia V; Sorrentino NC; Sambri I; Ezhova Y; Giuliano T; Cacace V; Nusco E; De Risi M; De Leonibus E; Schrader T; Klärner FG; Bitan G; Fraldi A
    Mol Ther; 2020 Apr; 28(4):1167-1176. PubMed ID: 32087148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    De Filippis C; Napoli B; Rigon L; Guarato G; Bauer R; Tomanin R; Orso G
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle is disturbed in mucopolysaccharidosis type II fibroblasts, and can be improved by genistein.
    Moskot M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Węsierska M; Bocheńska K; Węgrzyn G
    Gene; 2016 Jul; 585(1):100-103. PubMed ID: 27016302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
    Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
    Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
    J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.